Results for tag: "Ichthyosis Vulgaris Drug"

Ichthyosis Vulgaris (IV) is a chronic skin disorder characterized by dry, scaly skin. It is the most common form of ichthyosis, a family of genetic skin disorders. Treatment for IV typically involves the use of topical medications, such as emollients, keratolytics, and retinoids, as well as systemic medications, such as antibiotics and immunomodulators. Dermatological drugs are used to treat a variety of skin conditions, including IV, and the market for these drugs is growing. The market for dermatological drugs is driven by the increasing prevalence of skin diseases, the growing demand for cosmetic treatments, and the development of new drugs. The market is also driven by the increasing awareness of skin diseases, the rising demand for self-care products, and the increasing availability of generic drugs. The market for dermatological drugs is highly competitive, with a number of large pharmaceutical companies competing for market share. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Johnson & Johnson. Show Less Read more